2-Phenylimidazo[1,2-a]pyridine

Catalog No. :
ACFGWP068
CAS No. :
4105-21-9
Molecular Formula :
C13H10N2
Molecular Weight :
194.24

IUPAC Name:2-phenylimidazo[1,2-a]pyridine

2-Phenylimidazo[1,2-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$123.00Login to see priceIn stockIn stock
100g98%$343.00Login to see priceInquiryIn stock
500g98%$1331.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Phenylimidazo[1,2-a]pyridine
IUPAC Name2-phenylimidazo[1,2-a]pyridine
MDL No.MFCD00219254
Molecular FormulaC13H10N2
Molecular Weight194.24
SMILESC12=NC(C3=CC=CC=C3)=CN1C=CC=C2
InChI KeyKDHWCFCNNGUJCP-UHFFFAOYSA-N
SynonymDTXSID10276799 | SR-01000638986-1 | F3145-4971 | 3-Hydroxy-N-(naphthalen-1-yl)-2-naphthamide | HMS3087C06 | STK016628 | CCG-19767 | EU-0077265 | A21136 | Maybridge1_004380 | MLS002694050 | SCHEMBL966793 | AB04929 | doi:10.14272/KDHWCFCNNGUJCP-UHFFFAOYSA-N
CAS No.4105-21-9
PubChem CID201136

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFGWP068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKWTD320 route compound structure diagram
    ACKWTD32032654-45-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFGWP068 route product structure diagram
    ACFGWP0684105-21-9 In Stock
Inquiry

2. ACFGWP068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKWTD320 route compound structure diagram
    ACKWTD32032654-45-8 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACFGWP068 route product structure diagram
    ACFGWP0684105-21-9 In Stock
Inquiry

Comments (0)